ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,311Medicare Part D Prescriptions Filled, Including Refills

Rank: 449 out of 2429

$378K Total Retail Price of All Prescriptions

Rank: 482 out of 2429

359 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 359 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

12% of this provider’s 359 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 6,400 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LISINOPRIL 355 341 1 2
ATENOLOL 274 269 2 15
LEVOTHYROXINE SODIUM 249 236 3 3
FUROSEMIDE 247 225 4 5
SIMVASTATIN 232 208 5 1
OMEPRAZOLE 223 214 6 7
AMLODIPINE BESYLATE 218 210 7 4
HYDROCHLOROTHIAZIDE 210 202 8 10
PRAVASTATIN SODIUM 193 163 9 16
METOPROLOL TARTRATE 179 158 10 9
HYDROCODONE-ACETAMINOPHEN 168 110 S3 11 6
WARFARIN SODIUM 159 138 12 11
POTASSIUM CHLORIDE 142 111 13 14
DOXAZOSIN MESYLATE 126 122 14 105
TRAMADOL HCL 124 107 15 17
ALENDRONATE SODIUM 113 105 16 20
ATORVASTATIN CALCIUM 93 84 17 13
PANTOPRAZOLE SODIUM 81 48 18 34
FENOFIBRATE 80 75 19 48
GABAPENTIN 77 64 20 18
TRIAMTERENE-HCTZ 75 73 21 53
FLUOXETINE HCL 75 63 21 61
CITALOPRAM HBR 71 55 23 19
METFORMIN HCL 69 49 24 8
SERTRALINE HCL 69 47 24 23
TAMSULOSIN HCL 66 66 26 29
FLOVENT HFA 65 49 27 187
DIGOXIN 61 49 28 43
ZOLPIDEM TARTRATE 59 50 29 28
METOPROLOL SUCCINATE 59 59 29 12
CARVEDILOL 57 56 31 21
DONEPEZIL HCL 57 57 31 26
GLIPIZIDE 56 48 33 47
MIRTAZAPINE 56 56 33 63
DILTIAZEM 24HR ER 56 53 33 137
CLOPIDOGREL 54 49 36 31
FENTANYL 51 39 S2 37 59
CYCLOBENZAPRINE HCL 50 38 R 38 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.